Luminvest Wealth Management
ABBV icon

Luminvest Wealth Management’s AbbVie ABBV Stock Holding History

Luminvest Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1,646
Closed -$417K – 47
2026
Q2 		$417K Buy
1,646
+115
+8% +$24.7K 0.1% 41
2026
Q1 		$329K Hold
1,531
– – 0.09% 40
2025
Q4 		$350K Hold
1,531
– – 0.1% 38
2025
Q3 		$354K Hold
1,531
– – 0.12% 33
2025
Q2 		$285K Hold
1,531
– – 0.1% 34
2025
Q1 		$321K Hold
1,531
– – 0.13% 28
2024
Q4 		$272K Sell
1,531
-150
-9% -$27.6K 0.11% 29
2024
Q3 		$330K Hold
1,681
– – 0.14% 26
2024
Q2 		$295K Buy
+1,681
New +$278K 0.14% 27

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Luminvest Wealth Management's ABBV Position: Q3 2026 in Review

Luminvest Wealth Management sold out of AbbVie (ABBV) in Q3 2026, closing a stake of 1,646 shares — an estimated $417K sold.

Luminvest Wealth Management first reported a position in ABBV in Q2 2024 and held it in 9 quarters. The position peaked at $417K in Q2 2026. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Luminvest Wealth Management reported no remaining AbbVie position as of Q3 2026 after selling out during the quarter.
  • Luminvest Wealth Management sold 1,646 AbbVie shares in Q3 2026, an estimated $417K.
  • Luminvest Wealth Management first reported a position in AbbVie in Q2 2024 and held it in 9 quarters.
  • Luminvest Wealth Management's AbbVie position peaked at $417K in Q2 2026.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Luminvest Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.